What does Sophalex do?
SOPHALEX specializes in providing innovative solutions in the field of life sciences. The company focuses on the development and commercialization of advanced therapeutic products and services. With a commitment to quality and effectiveness, SOPHALEX aims to improve patient outcomes through its cutting-edge technologies.
- Activities
- Signals
-
ProfitableProfitable € 379K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.04MStrong equity provides a buffer against setbacks.
Low riskLow risk 89.2%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.95A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 277KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 379KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2020
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
380K
|
€
670K
|
€
146K
|
€
261K
|
|
|
€
379K
|
€
669K
|
€
145K
|
€
261K
|
|
|
€
277K
|
€
1.13M
|
€
201K
|
€
187K
|
|
|
€
3.04M
|
€
2.77M
|
€
2.08M
|
€
1.88M
|
|
|
89.24%
|
86.53%
|
73.65%
|
66.31%
|
|
|
€
367K
|
€
431K
|
€
744K
|
€
954K
|
|
|
€
1.06M
|
€
857K
|
€
468K
|
€
247K
|
Publications 6
All publications- Wijziging Rechtsvorm - Ontslagen - Benoemingen - Algemene Vergadering - Boekjaar 11/02/2022
- Me. - Jaarrekening 31.12.2015, Ggk 23.04.2016, Ngl 10.08.2016 16424-0576-015 19/08/2016
- Me. - Jaarrekening 31.12.2014, Ggk 25.04.2015, Ngl 17.08.2015 15431-0167-015 20/08/2015
- Me. - Jaarrekening 31.12.2013, Ggk 26.04.2014, Ngl 22.08.2014 14467-0058-014 28/08/2014
- Me. - Jaarrekening 31.12.2012, Ggk 27.04.2013, Ngl 26.08.2013 13470-0134-010 30/08/2013
Frequently asked questions
Answers to the most common questions about Sophalex, based on official government data and the filed annual accounts.
What is the VAT number of Sophalex?
The VAT number of Sophalex is BE0842.026.019.
When was Sophalex established?
Sophalex was founded in 21-12-2011.
What is the official address of Sophalex?
The official address of Sophalex is Langemarkseweg 2 Ieper 8904.
What is the legal form of Sophalex?
The juridical form of Sophalex is Private limited company (BV/SRL).
What is the annual revenue of Sophalex?
The 2024 accounts of Sophalex do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Sophalex do?
SOPHALEX specializes in providing innovative solutions in the field of life sciences. The company focuses on the development and commercialization of advanced therapeutic products and services. With a commitment to quality and effectiveness, SOPHALEX aims to improve patient outcomes through its cutting-edge technologies.
Is Sophalex a reliable company?
Sophalex is a registered Rechtspersoon with company number 0842.026.019 and can be verified through the official CBE database.
What is the credit limit of Sophalex?
The estimated credit limit of Sophalex is €517,494.
Is Sophalex still active?
Sophalex currently has the status "Normal situation" and is active.